Cargando…
Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy
Serum lactate dehydrogenase (LDH) concentrations correlate with tumor progression and poor outcome. We evaluated the predictive value of serum LDH level for overall survival (OS) of patients with advanced pancreatic cancer after gemcitabine-based chemotherapy. We retrospectively enrolled 364 patient...
Autores principales: | Yu, Shu-Lin, Xu, Li-Tao, Qi, Qi, Geng, Ya-Wen, Chen, Hao, Meng, Zhi-Qiang, Wang, Peng, Chen, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366928/ https://www.ncbi.nlm.nih.gov/pubmed/28345594 http://dx.doi.org/10.1038/srep45194 |
Ejemplares similares
-
Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma
por: Fu, Yucheng, et al.
Publicado: (2018) -
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia
por: Maftouh, M, et al.
Publicado: (2014) -
Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer
por: Wang, Haocheng, et al.
Publicado: (2021) -
Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients
por: Chen, Zhan-hong, et al.
Publicado: (2018) -
Improvement of Diagnostic Accuracy for Pancreatic Cancer with Serum Lactate Dehydrogenase
por: Wang, Xi, et al.
Publicado: (2021)